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The transcription factor REST silences neuronal gene expression in non-neuronal cells. In neurons, the protein is sequestered in the
cytoplasm in part through binding to huntingtin. Polyglutamine expansions in huntingtin, which causes Huntington’s disease (HD),
abrogates REST-huntingtin binding. Consequently, REST translocates to the nucleus, occupies RE1 repressor sequences and decreases
neuronal geneexpression. In thiswork,we found that levels of severalmicroRNAs (miRNAs)withupstreamRE1sites aredecreased inHD
patient cortices relative to healthy controls. Interestingly, one of these, the bifunctional brain enriched miR-9/miR-9*, targets two
components of the REST complex: miR-9 targets REST and miR-9* targets CoREST. These data provide evidence for a double negative
feedback loop between the REST silencing complex and the miRNAs it regulates.
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Introduction
Huntington’s disease (HD) is an autosomal dominant neurode-
generative disease caused by CAG trinucleotide repeat expansion
in huntingtin, which encodes Huntingtin (Htt) (The Hunting-
ton’s Disease Collaborative Research Group, 1993). Patients with
HD experience abnormal motor movements, cognitive decline
and psychiatric disturbances that frequently result in premature
death. Although Htt is ubiquitously expressed, patients with HD
show predominantly CNS manifestations. One of the molecular
phenotypes in HD patients is transcriptional misregulation in
striatum and distinct cortical regions (Hodges et al., 2006). One
putative mechanism underlying the transcriptional changes is
aberrant cellular distribution of the transcriptional repressor
RE1-silencing transcription factor (REST, also known as neuron-
restrictive silencer factor, NRSF) (Lunyak et al., 2002; Zuccato et
al., 2003, 2007).
REST expression is highest in pluripotent stem cells and de-
creases upon restriction to neural progenitor cells and subse-
quently to neurons (Ballas et al., 2005). In mature, healthy neu-
rons, REST is expressed at low levels and primarily sequestered in
the cytoplasm in part through interaction with Htt (Zuccato et
al., 2003). However, in patients withHD,mutantHtt fails to bind
REST, enabling its nuclear translocation (Zuccato et al., 2003).
Once in the nucleus, REST can bind RE1 consensus sequences
and recruit corepressors including mSin3, REST corepressor 1
(CoREST, also known as RCOR1), andmethyl CpG binding pro-
tein 2 (MeCP2) (Andre´s et al., 1999) to inactivate neuron-specific
genes (Zuccato et al., 2003; Conaco et al., 2006). Similarly, REST
repressor complex binding to RE1 sequences upstream of
miRNA transcripts may alter miRNA expression profiles
(Conaco et al., 2006; Klein et al., 2007).
MiRNAs are small noncoding RNAs that participate in post-
transcriptional regulation through sequence complementarity to
the 3 untranslated regions (UTRs) of mRNAs. Binding of a
miRNA to its target mRNA typically results in its translational
repression through mRNA degradation or translational inhibi-
tion (Bartel, 2004). Given their essential role in modulation of
cellular processes such as cell fate, identity, and function (Sem-
pere et al., 2004; Kim et al., 2007; Makeyev et al., 2007), we
screened a panel of predicted REST-regulated miRNAs (Jothi et
al., 2008) in samples collected from healthy control and HD pa-
tient brains (HD grades 1–4). Our data showmiRNAmisregula-
tion during HD progression, and moreover, evidence that miR-
9/miR-9*, a REST-regulated miRNA, targets two components of
the REST silencing complex.
Materials andMethods
Human tissues. Postmortem brain samples were obtained from the New
York Brain Bank (Columbia University, New York, NY), the Harvard
Brain Bank (HarvardUniversity, Cambridge,MA), and theNewZealand
Neurological Foundation Brain Bank (University of Auckland, Auck-
land, New Zealand) with informed consent from families. Tissues were
collected fromBrodmann’s area 4 (BA4) cortex of healthy control (n 7;
ages 46–62) and HD grade 1 (n 7; ages 42–70), 2 (n 6; ages 45–78),
3 (n  2; ages 60–65), and 4 (n  4; 53–60). CAG repeat length for
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controls was 16–21; HD grade 1–4 was 37–46. Postmortem time for
brain samples was 2–20 h.
miRNA expression profiling. RNA was collected from cortex using
TRIzoL (Invitrogen). Expression profiles for the mature miRNAs were
obtained by quantitative PCR (QPCR) using TaqMan Array Human
MiRNA Panel v1.0 (TLDA) or TaqManMiRNA Assays (Applied Biosys-
tems; ABI) according to the manufacture on an ABI Prism 7900HT.
Mature miRNAs were normalized to RNU48 and are shown as fold
change relative to controls.
Cloning 3UTRs and endogenousmiRNAs.The 3UTRof REST (NCBI
36, Oct 2005) (supplemental Fig. S2, available at www.jneurosci.org as
supplementalmaterial) was verified inNT2, Neuroblastoma, A549, HEK
293 and HeLa cells by sequencing of cDNAs prepared from TRIzoL (In-
vitrogen) isolated RNA, then PCR amplified using Expand High Fidelity
DNA polymerase (RocheApplied Science) and 3 UTR specific primers
(see supplemental methods, available at www.jneurosci.org). Both REST
and CoREST 3 UTRs were cloned from HEK 293 cDNAs into
psiCHECK-2 (Promega) downstream ofRenilla luciferase. HumanmiR-
9–3 loci were amplified from HEK 293 genomic DNA and cloned into a
Zero Blunt TOPO (Invitrogen) containing a Pol III mouse U6 promoter.
mU6miR-124a-1 andmiR-132 hairpins were cloned as described above.
Perfect target controls. Perfect target (PT) controls for miR-9, 9* and
132 weremade by complexing 8M sense and antisense oligonucleotides
containing a site with perfect complementarity to the mature miRNA
and random flanking sequence. PCR cycles were 2 times at 94°C 15 s,
67°C 30 s, 72°C 1 min and extension for 1 min, 72°C, then cloned down-
stream of Renilla luciferase.
Cell culture, transfections, and luciferase assays. HEK 293 and NT2
[NTERA-2 c1.D1, lot number 4742175 from ATCC (CFL-1973)] cells
were cultured in DMEM supplemented with 10% heat-inactivated fetal
calf serumat37°Cand5%CO2.Cellswere transfected in triplicateon24-well
plateswithLipofectamine2000 (Invitrogen)per the instructionsof theman-
ufacturer, with 4 ng of psiCHECK-3UTR plasmid and 4–400 ng of mU6
miRNA or pre-miR-9, 9* or negative controls (Ambion). Anti-miRNA res-
cue experimentswereperformedbycotransfectingpsiCHECK-3UTRplas-
mids in conjunction with mU6miR-9/miR-9* and anti-miRs 9–3, 9–3* or
negative controls (Ambion). ForNT2differentiation, 0.01mMall-trans reti-
noic acid (Sigma-Aldrich) was added to the media for 5 d.
Luciferase was measured 24 h later on a moon light luminometer
(PharMingen). Renilla luciferase was normalized to firefly luciferase and
is shown relative to controls.
“Target site protectors” (TSPs) were designed antisense to predicted
3UTRMRE of REST and CoREST (supplemental methods, available at
www.jneurosci.org as supplemental material). Optimized TSPs were designed
withM.Behlke, IntegratedDNATechnologies andused at 0.01–0.1 nM.
siRNAs. HEK 293 and NT2 cells were transfected with 5 nM silencer
select siRNAs to REST (s11933) (si-REST), or a scrambled negative con-
trol (si-NEG) (Ambion) as above. Total RNA was harvested 48 h later
with TRIzol (Invitrogen), reverse transcribed with High Capacity cDNA
Reverse Transcription Kit, then analyzed by QPCR using REST or 18 s
rRNA TaqMan Gene Expression Assays (ABI).
Western blots. Protein was harvested using RIPA buffer (Pierce) and
1 protease inhibitor using standard techniques and quantified using
DC Protein Assay (Bio-Rad). Protein extracts were separated on a 7%
acrylamide gel and transferred to Immobilon PDVF transfer membranes
(Millipore). Primary antibodies to REST/NRSF (1:500; ab21635),
CoREST (1:1000; ab56165) (both Abcam) and -actin (1:10,000; Sigma)
were used. Blots were developed using ECL PlusWestern Blotting Detec-
tion System (GE Healthcare) and quantified by AlphaEase FC (Alpha
Innotech, version 5.0.1).
Statistical analysis.Data were analyzed by one-way ANOVA, followed
by Dunnett’s post hoc analysis (GraphPad InStat, GraphPad Software,
version 3.06).
Results
miRNA expression changes with HD progression
TodeterminewhethermiRNAs are affectedwithHDdisease pro-
gression, we isolated total RNA from control and HD grade 1–4
brain samples. We specifically chose Brodmann’s area 4 (BA4)
cortex because prior work indicates widespread transcriptional
changes in this region in HD patients (Hodges et al., 2006). We
found five predicted REST-regulatedmiRs to be significantly dif-
ferent with increasing HD grade: miR-9 (F(3,22)  9.876, p 
0.0003), miR-9* (F(3,22) 6.799, p 0.0021), miR-29b (F(3,22)
3.658, p  0.0281), miR-124a (F(3,16)  7.833, p  0.001), and
miR-132 (F(3,22)  7.611 p  0.0011) (Fig. 1A). For miR-139,
miR-135b, andmiR-212 no significant differences were observed
with increasing disease severity, while miR-218 demonstrated a
trend toward increasing expression with disease grade (Fig. 1A).
Previous work by Johnson and colleagues measured precursor
miRNA levels inHD brain of unknown disease grade (Johnson et
al., 2008). Interestingly, and in contrast to our findings, their
work showed no change inmiR-124a, elevated levels of miR-29a,
and decreased levels of miR-132. We saw a trend toward in-
creased miR-29a in tissue from early stage HD, followed by di-
minished levels. Also, we found no change in miR-132 at stages 1
and 2, but significant upregulation later. The differences in pre-
cursor (Johnson et al., 2008) versus mature miRNA levels (this
study) is not surprising given recent reports describing posttran-
scriptional regulation of miRNAs (Obernosterer et al., 2006; Lee
et al., 2008).
We next used a QPCR based miRNA array platform to evalu-
ate the expression profiles of 365 mature miRNAs in BA4 cortex
from control and early stage HD (grades 1 and 2). We found an
additional 7 miRNAs that were decreased in HD1 and/or HD2
samples (supplemental Table 1, available at www.jneurosci.org as
supplemental material). Also, miR-196a and miR-486 were sig-
nificantly increased by nearly sixfold and threefold, respectively,
in HD1 samples relative to controls. These results provide addi-
tional evidence for differential regulation of select miRNAs in
HD.
REST and CoREST contain predicted miR-9 and 9*
regulatory sites
MiR-9 and miR-9*, which decreased early in HD (Fig. 1A), are
processed from the same primary transcript from 3 genomic loci
(miR-9–1, 9–2 and 9–3); miR-9–1 and miR-9–3 both have up-
stream RE1 sequences that can be occupied by REST (Conaco et
al., 2006; Johnson et al., 2008). We amplified the human miR-
9–3 locus from HEK 293 cells and cloned it downstream of the
mouse U6 promoter (mU6 miR-9/9*) for heterologous expres-
sion of miR-9/miR-9*. The cloned mU6 miR-9/9* plasmid re-
sulted in efficient expression and processing of both miR-9 and
miR-9* as determined by knockdown of perfect target controls
(PT) (supplemental Fig. S1, available at www.jneurosci.org as
supplemental material).
Among the targets predicted for miR-9 and 9* are REST and
CoREST [TargetScan 4.1 (Lewis et al., 2003)]. This is interesting
given the putative role of the REST repressor complex in mis-
regulation of genes in HD (Zuccato et al., 2003). The 3 UTRs of
REST (supplemental Fig. S2, available at www.jneurosci.org as
supplemental material) and CoREST (supplemental Fig. S3,
available atwww.jneurosci.org as supplementalmaterial) contain
miRNA recognition elements (MRE) for miR-9, miR-9*, miR-
132 and miR-124a (CoREST only) (Wu and Xie, 2006). As a first
test of miR-9/9* and REST or CoREST interaction, we cloned the
3UTR of REST and CoREST downstream from the gene encod-
ing Renilla luciferase. Cotransfection of mU6 miR-9/9* with
REST or CoREST-3 UTR reporter constructs significantly de-
creased Renilla luciferase activity compared with controls (F(2,6)
 333.08, p  0.0001 and F(2,6)  16.134, p  0.0034 for REST
and CoREST, respectively) (Fig. 1B,C). Consistent with these
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reporter-based assays, over expression ofmU6miR-9/9*, but not
mU6 miR-124a or 132, in HEK 293 cells significantly reduced
REST (F(2,12)  26.006, p  0.0001) and CoREST (F(2,12) 
24.017, p  0.0001) expression (Fig. 1D,E). Therefore, the pre-
dicted MREs in CoREST and REST for miR-9/9*, but not miR-
124a and miR-132, are functional (Fig. 1D,E).
miR-9 targets REST
The full-length 3 UTR of REST (supplemental Fig. S2, available
at www.jneurosci.org as supplemental material) and CoREST
(supplemental Fig S3, available at www.jneurosci.org as supple-
mental material) contain several predicted conserved MRE sites
for miR-9 andmiR-9*. Because mU6miR-9/9* produces mature
miR-9 andmiR-9* upon processing (supplemental Fig. S1, avail-
able at www.jneurosci.org as supplemental material), we used
artificial precursor miRNAs (pre-miR) that release a single ma-
ture miRNA (in this case miR-9 or miR-9*) and anti-miRNAs
(which are antisense to each mature miRNA) to determine
whether there is preferential activity for miR-9, miR-9*, or both
on REST and/or CoREST. Cotransfection of 15 nM pre-miR-9
with luciferase reporters containing the 3 UTR of REST signifi-
cantly reduced reporter gene expression (F(2,9)  35.524, p 
0.0001) in contrast to pre-miR-9* or a negative control pre-miR
(Fig. 2A). [Specificity of the pre-miRs was confirmed using re-
porter constructs containing perfect miRNA target sites (supple-
mental Fig. S4, available at www.jneurosci.org as supplemental
material)]. Also, anti-miR-9, but not anti-miR-9* rescued the
inhibition of Renilla luciferase activity seen upon cotransfecting
mU6miR-9/9* with the REST 3UTR reporter plasmid (F(2,6)
19.539, p  0.0024) (supplemental Fig. S5, available at www.
jneurosci.org as supplemental material). To extend the reporter
studies to endogenous REST, we transfected HEK 293 cells with
pre-miR-9. This resulted in significant knockdown of endoge-
nous REST protein expression (F(2,9) 7.552, p 0.0119) com-
pared with pre-miR-9* or the pre-miR negative control (Fig.
2B,C). Together, these results suggest that the miR-9 predicted
MREs in the 3 UTR of REST are functional, in contrast to the
miR-9* predicted MREs.
We next designed a LNA-modified oligonucleotide as a TSP,
with sequence complementarity to the predicted miR-9 binding
site in the REST 3 UTR (supplemental Fig. S6, available at
www.jneurosci.org as supplemental material). TSPs contain se-
quences antisense to theMRE along with flanking sequences and
serve to block specific miRNA-target site interactions within a 3
Figure 1. Several REST-regulatedmiRNA levels change with HD progression, andmiR-9/9* targets a silencing complex. A, Longitudinal expression profiles of REST-regulatedmiRNAs in HD and
healthy control cortex (BA4)HDgrade 1, 2, and3/4 asmeasuredbyQPCR.MaturemiRNA levels inHDbrain relative to controls (*p0.05, **p0.01).B,C,miR-9/9* reduces expression of reporter
proteins containing the 3 UTR of REST or CoREST. B, HEK 293 cells were cotransfected with a vector expressing miR-9/9* (mU6miR-9/9*) and REST 3 UTR luciferase reporters. Relative luciferase
activity was measured 24 h later. Increasing doses of mU6miR-9/9* relative to target caused a dose-dependent decrease in relative luciferase. Control vectors containing a single site with perfect
complementarity to mature miR-9 (miR-9-PT) or miR-9* (miR-9*-PT) were included as positive controls (n 3). C, Experiments as in (B) with CoREST 3 UTR luciferase reporters (n 3). D, E,
Transfection of HEK 293 cells with mU6 miR-9/9* reduces both REST and CoREST protein expression levels 24 h later. D, Representative Western blots and densitometry for (E) REST (n 5) and
CoREST (n 5). Histograms showmeanSEM after normalization to-actin levels. *p 0.05, **p 0.01.
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UTR. These are distinct from anti-miRs,
which impair all miRNA-target interac-
tions. Cotransfection of HEK 293 cells
with the REST 3 UTR reporter plasmid,
the mU6 miR-9/9* plasmid and TSP
(targeting the terminal MRE in REST)
(supplemental Fig. S2, available at www.
jneurosci.org as supplemental material)
showed protection frommRNA-mediated
silencing compared with mU6 miR-9/9*-
treated cells (F(2,9)  38.395, p  0.0001)
(supplemental Fig. S6, available at www.
jneurosci.org as supplemental material).
Consistent with these observations, REST
levels in HEK 293 cells, which decreased
upon mU6 miR-9/9* transfection (Fig.
1D,E) was rescued by TSP (Student’s t
test, p 0.05), but not a control TSP (TSP
Neg) (Fig. 2D).
miR-9* targets CoREST
We used similar approaches to ascertain
whether miR-9, miR-9* or both were
functional in regulating CoREST. Co-
transfection of the CoREST 3 UTR re-
porter plasmid and 5 or 15 nM pre-miR-9*
reduced reporter expression compared
with controls (F(2,11) 41.612, p 0.0001
and F(2,11)  7.423, p  0.0091, respec-
tively), unlike miR-9 (Fig. 3A). Also, only
pre-miR-9* significantly reduced endoge-
nous CoREST expression in HEK 293 cells
(F(2,9)  11.173, p  0.0036) (Fig. 3B,C).
Also, reduced CoREST expression after
transfection of HEK 293 cells with mU6
miR-9/9* (Fig. 1D,E) was relieved upon
anti-miR-9* cotransfection (supplemental
Fig. S7, available at www.jneurosci.org as
supplemental material).
Wenext usedTSPs against the conserved
predictedmiR-9* binding site in CoREST to
test its functionality (supplemental Fig. S8,
available at www.jneurosci.org as supple-
mental material). Cotransfection of mU6
miR-9/9* in the presence of TSP signifi-
cantly rescued reporter gene expression
compared with mU6 miR-9/9*-treated cells
(F(2,6) 32.882, p 0.0006) (supplemental
Fig. S8, available at www.jneurosci.org as
supplemental material). Endogenous CoR-
EST protein expression, which was reduced
after pre-miR-9* transfection, increased
upon cotransfection of TSP (Student’s t
test, p  0.05) but not TSP Neg (Fig. 3D).
These data provide support for a miR-9*
MRE in regulating CoREST.
Finally, we tested how reducing REST
expression impacts endogenous miR-9
levels in HEK 293 and NT2 cells. In both
cell lines, short-term reduction in REST
expression resulted in enhancedmiR-9 ex-
pression ( p 0.05) and processing as de-
termined by measuring level of mature
Figure 2. miR-9 targets the 3 UTR of REST. A, Cotransfection of HEK 293 cells with luciferase reporters containing the 3 UTR
of REST in the presence of increasing concentrations (0.1, 1.0, 5.0, or 15.0 nM) of artificial pre-miR-9 reduces relative luciferase
activity (n4).B,C, KnockdownofREST following transfectionofHEK293 cellswithpre-miR-9 (30nM).A representativeWestern
blot (B) and the densitometry from (n 4) independent experiments (C) after normalization to-actin. Data aremeanSEM;
*p0.05, **p0.01.D, A representativeWesternblot showing that target site protectors (TSP) designed toblock thepredicted
miR-9 binding site of REST (TSP) rescuesmU6miR-9/9*-mediated knockdown of REST. HEK 293 cells were cotransfected with
mU6miR-9/9*andTSPor TSPnegative control (Neg) andREST levelsmeasured in cell lysates 24h later. Densitometry fromn
4 independent experiments indicate increased REST in TSP (0.97 0.065)-treated versus TSP Neg (0.54 0.212)-treated
cells.
Figure 3. miR-9* targets the 3 UTR of CoREST. A, Cotransfection of HEK 293 cells with luciferase reporters containing the 3
UTR of CoREST in the presence of increasing concentrations (0.1, 1.0, 5.0, or 15.0 nM) of artificial pre-miR-9* reduces relative
luciferase activity (n 5). B, C, CoREST levels are reduced following transfection of HEK 293 cells with pre-miR-9* (30 nM). A
representativeWestern blot (B) and densitometry (n 4) (C) after normalized-actin levels. Data aremean SEM; *p 0.05,
**p 0.01.D, TSP designed the predictedmiR-9* binding site of CoREST (TSP) rescues pre-miR-9*mediated knockdown (B).
HEK 293 cells were cotransfected with pre-miR-9* (15 nM) and TSP or TSP Neg and CoREST levels measured in cell lysates by
Western blot 24 h later. Densitometry from n  4 independent experiments indicate increased CoREST in TSP (1.02 
0.05)-treated versus TSP Neg (0.565 0.08)-treated cells.
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miR (supplemental Fig. S9, available at www.jneurosci.org as
supplemental material). These findings provide support to pre-
vious studies which showed REST occupancy on miR-9–1 and
miR-9–3 (Conaco et al., 2006) and provide functional evidence
for a negative feed back look between components of the REST
complex and REST-regulated miRNAs.
Discussion
The transcriptional repressor REST is mislocalized in brains of
patients with HD, with increased nuclear localization and occu-
pancy at RE1 sites comparedwith healthy controls (Zuccato et al.,
2003, 2007). REST interacts with CoREST and other transcrip-
tional repressors to regulate neuronal gene expression and lin-
eage commitment through its direct control of both mRNA and,
as shown more recently, miRNA transcripts (Vo et al., 2005;
Conaco et al., 2006; Mortazavi et al., 2006; Visvanathan et al.,
2007). Indeed, canonical and noncanonical REST bindingmotifs
have recently been mapped in close proximity to 22 miRNA sites
in the human genome, including several of which are located
within close proximity to neuron enrichedmiRNAs (Bruce et al.,
2004; Jothi et al., 2008).
In this study we found several miRNAs to be significantly
misregulated among RNA harvested from HD brains compared
with those of healthy controls. Of these, the bifunctional miR-9/
miR-9* targets two components of the REST repressor complex:
miR-9 targets REST and miR-9* targets CoREST. MiR-132 has
been shown to target MeCP2 (Klein et al., 2007), which can in-
teract with REST and CoREST to suppress transcription (Lunyak
et al., 2002). Double negative feedback networks have been re-
ported in other systems where critical balancing of multiple fac-
tors is essential (Tsang et al., 2007).
Recent studies on the brain enriched miR-9 have revealed its
importance in development and lineage commitment (Sempere
et al., 2004; Krichevsky et al., 2006). In zebrafish, miR-9 is impor-
tant for midbrain-hindbrain boundary definition (Leucht et al.,
2008). In mouse cortical development, miR-9 appears necessary
for appropriate differentiation of Cajal-Retzius cells (Shibata et
al., 2008). In addition to miR-9/miR-9*, mature miR-124a is
significantly reduced in HD cortices. miR-124 promotes neuro-
nal differentiation, in part through targeting of a splicing factor
(Makeyev et al., 2007). Also, over-expression of miR-124 in non-
neuronal cells induces gene expression profiles to a neuronal phe-
notype (Lim et al., 2005). Interestingly, genes related to neuro-
genesis are highly overrepresented among the genes changed in
expression in the cortex (BA4) of HD patients (Hodges et al.,
2006). This may reflect a dedifferentiation mediated by aberrant
REST localization, because REST mRNA levels do not change
significantly inHD (Hodges et al., 2006), as well as global changes
in miR-9/9* and miR-124a target levels. Whether diminished
levels of miR-9/9*, miR-124a and other miRNAs in HD cortex
result from, or contribute to, the dedifferentiation profile is cur-
rently under study.
In summary, we show that several REST-regulated miRNAs
decrease with disease progression in HD brain. We demonstrate
that among these, miR-9 and miR-9* target REST and CoREST,
respectively. Our findings, together with recent work showing
that REST can be regulated by ubiquitin-mediated proteolysis
(Westbrook et al., 2008) underscore the importance ofmaintain-
ing appropriate levels and intracellular localization (Zuccato et
al., 2003) of this repressor complex for appropriate gene tran-
scription and lineage commitment.
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